The Mesothelioma Applied Research Foundation is pleased to announce that Boris Sepesi, MD has joined its board of directors, the organization’s main governing board.
Dr. Boris Sepesi is an associate professor in the department of thoracic and cardiovascular surgery at the University of Texas MD Anderson Cancer Center. Dr. Sepesi was born in former Czechoslovakia and earned his medical degree with honors from Jagiellonian University Medical College in Krakow, Poland. He completed internship and residency in general surgery at the University of Rochester Medical Center in Rochester, NY, and then completed a clinical fellowship in cardiothoracic surgery at MD Anderson Cancer Center/Methodist training program, where he mainly focused on the treatment and management of complex thoracic oncological diagnoses, including mesothelioma.
The Foundation’s board of directors assumes responsibility for ensuring the organization’s long-term financial stability and integrity and – through consensus and majority vote with the other members – for governing the organization and setting its strategic direction and broad policy directives.
The full list of volunteer board members includes:
- Dr. Marjorie Zauderer, Chair – Memorial Sloan Kettering Cancer Center
- Dr. Keith Cengel, Director – University of Pennsylvania
- Rich DeAugustinis, Director
- Dr. Patrick Forde, Director – Johns Hopkins
- Dr. Jason Foster, Director – University of Nebraska Medical Center
- Ross Kellman, Director
- Kristin Lofgren, CPA, Treasurer
- Dr. Aaron Mansfield, Director – Mayo Clinic
- Dr. R. Taylor Ripley, Director – Baylor College of Medicine
- Buerkley Rose, MSN, RN, Director – The University of Chicago
- Dr. Boris Sepesi, Director – MD Anderson Cancer Center
- Dr. Daniel Sterman, Director – New York University
- Dr. Jamie Stevenson, Director – Cleveland Clinic
- Dr. Antoinette Wozniak, Director – University of Pittsburgh Medical Center
- Bill Ziegler, Secretary
The Mesothelioma Applied Research Foundation is the only 501(c)(3) nonprofit organization working to eradicate mesothelioma and end this national tragedy. Its programs include the funding of promising and peer-reviewed research, education, support and advocacy. The organization strives to bring together thought-leaders in the field to identify the most direct path to a cure.
